Are Seroprevalence Estimates for Severe Acute Respiratory Syndrome Coronavirus 2 Biased?
Open accessThe DOI matches its Crossref record; 4 of the 4 references it cites were found in a registry or an index.
Abstract
Biased seroprevalence estimates can occur using serological assays optimized with validation sets unrepresentative of disease spectrum in the general population. Correct interpretation of serosurveys for severe acute respiratory syndrome coronavirus 2 requires quantifying variations in sensitivity with disease severity and over time.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Antibody responses to SARS-CoV-2 in patients with COVID-19
Long, Q.-X., Liu, B.-Z., Deng, H.-J., Wu, G.-C., Deng, K., Chen, Y.-K., Liao, P., Qiu, J.-F., Lin, Y., Cai, X.-F., et al. (2020) · Nature Medicine · doi:10.1038/s41591-020-0897-1 · Cited by 2,876
Clinical and immunological assessment of asymptomatic SARS-CoV-2 infections
Long, Q.-X., Tang, X.-J., Shi, Q.-L., Li, Q., Deng, H.-J., Yuan, J., Hu, J.-L., Xu, W., Zhang, Y., Lv, F.-J., et al. (2020) · Nature Medicine · doi:10.1038/s41591-020-0965-6 · Cited by 2,686
Okba, N. M. A., Müller, M. A., Li, W., Wang, C., GeurtsvanKessel, C. H., Corman, V. M., Lamers, M. M., Sikkema, R. S., de Bruin, E., Chandler, F. D., et al. (2020) · Emerging Infectious Diseases · doi:10.3201/eid2607.200841 · Cited by 1,614
Wu, F., Wang, A., Liu, M., Wang, Q., Chen, J., Xia, S., Ling, Y., Zhang, Y., Xun, J., Lu, L., et al. (2020) · doi:10.1101/2020.03.30.20047365 · Cited by 754
Research works printed but not linked: 12
- Stringhini, 2020, Repeated seroprevalence of anti-SARS-CoV-2 IgG antibodies in a population-based sample from Geneva, Switzerland, Lancet, 396, P313, 10.1016/S0140-6736(20)31304-0 · DOI · Paper page
- US Food and Drug Administration, 2020, EUA authorized serology test performance
- Krammer, 2020, Serology assays to manage COVID-19., 1060
- Whitman, 2020, Test performance evaluation of SARS-CoV-2 serological assays, medRxiv [Preprint]
- Cervia, 2020, Systemic and mucosal antibody secretion specific to SARS-CoV-2 during mild versus severe COVID-19, bioRxiv [Preprint]
- Solbach, 2020, Antibody profiling of COVID-19 patients in an urban low-incidence region in Northern Germany, medRxiv [Preprint]
- Bartolini, 2020, Immunochromatographic assays for COVID-19 epidemiological screening: our experience, medRxiv
- Lynch, 2020, Magnitude and kinetics of anti-SARS-CoV-2 antibody responses and their relationship to disease severity, Clin Infect Dis, 10.1093/cid/ciaa979 · DOI · Paper page
- Lei, 2020, Antibody dynamics to SARS-CoV-2 in asymptomatic and mild COVID-19 patients, medRxiv
- Sethuraman, Interpreting diagnostic tests for SARS-CoV-2, JAMA
- Iyer, 2020, Dynamics and significance of the antibody response to SARS-CoV-2 infection, medRxiv
- Diggle, 2011, Estimating prevalence using an imperfect test, Epidemiol Res Int, 1, 10.1155/2011/608719 · DOI · Paper page
Cited by
Infectious disease in an era of global change
Baker, R. E., Mahmud, A. S., Miller, I. F., Rajeev, M., Rasambainarivo, F., Rice, B. L., Takahashi, S., Tatem, A. J., Wagner, C. E., Wang, L.-F., et al. (2022) · Nature Reviews Microbiology · doi:10.1038/s41579-021-00639-z · Cited by 2,059
Self-citationAge-specific mortality and immunity patterns of SARS-CoV-2
O’Driscoll, M., Ribeiro Dos Santos, G., Wang, L., Cummings, D. A. T., Azman, A. S., Paireau, J., Fontanet, A., Cauchemez, S., & Salje, H. (2021) · Nature · doi:10.1038/s41586-020-2918-0 · Cited by 1,210
Meyerowitz-Katz, G., & Merone, L. (2020) · International Journal of Infectious Diseases · doi:10.1016/j.ijid.2020.09.1464 · Cited by 566
Hallal, P. C., Hartwig, F. P., Horta, B. L., Silveira, M. F., Struchiner, C. J., Vidaletti, L. P., Neumann, N. A., Pellanda, L. C., Dellagostin, O. A., Burattini, M. N., et al. (2020) · The Lancet Global Health · doi:10.1016/s2214-109x(20)30387-9 · Cited by 398
Testing at scale during the COVID-19 pandemic
Mercer, T. R., & Salit, M. (2021) · Nature Reviews Genetics · doi:10.1038/s41576-021-00360-w · Cited by 387
Metadata
- Authors
- Takahashi, S., Greenhouse, B., & Rodríguez-Barraquer, I.
- Venue
- The Journal of Infectious Diseases
- Publisher
- Oxford University Press (OUP)
- Published
- 2020-08-28
- Volume
- 222
- Issue
- 11
- Pages
- 1772-1775
- ISSN
- 0022-1899 (ISSN-L)
- 1537-6613
- OpenAlex
- W3080346431
- Cited by
- 80
- References
- 4
- FWCI
- 1.99
- Type
- journal article
- Language
- en
- Open access
- bronze
- Licence
- academic.oup.com/journals/pages/open_access/funder_policies/chorus/standard_publication_model (vor)
- Funders
- Rhodes Trust
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Are Seroprevalence Estimates for Severe Acute Respiratory Syndrome Coronavirus 2 Biased? https://app.cochat.ai/papers/10.1093/infdis/jiaa523
- The paper
- Takahashi, S., Greenhouse, B., & Rodríguez-Barraquer, I. (2020). Are Seroprevalence Estimates for Severe Acute Respiratory Syndrome Coronavirus 2 Biased? The Journal of Infectious Diseases. https://doi.org/10.1093/infdis/jiaa523
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.